These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2778373)

  • 21. Bone scintigraphy in patients with breast cancer: malignant involvement of the sternum.
    Ohtake E; Murata H; Maruno H
    Radiat Med; 1994; 12(1):25-8. PubMed ID: 8016400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of osseous metastasis in bone scintigraphy.
    Davila D; Antoniou A; Chaudhry MA
    Semin Nucl Med; 2015 Jan; 45(1):3-15. PubMed ID: 25475375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone scintigraphy in metastases].
    Cayla J; Basset JY
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):317-23. PubMed ID: 3738395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radiologic detection of metastatic bone tumors].
    Sugimoto E; Tamagawa M; Okawara K; Osawa T
    Gan No Rinsho; 1988 Aug; 34(10):1491-7. PubMed ID: 3172506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expressiveness of Bone Markers in Breast Cancer with Bone Metastases.
    Zulauf N; Brüggmann D; Groneberg D; Oremek GM
    Oncology; 2019; 97(4):236-244. PubMed ID: 31412345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical value of radionuclide whole body bone imaging in the diagnosis of skeletal metastasis].
    Chen YQ
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):193-5. PubMed ID: 2612331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Breast cancer: the role of scintigraphy in the initial evaluation and follow-up of patients with small tumors (T less than or equal to 3 cm)].
    Lagrange JL; Hoch M; Courdi A; Darcourt J; Benoiel J; Namer M; Hery M; Abbes M; Monticelli J; Schneider M
    Bull Cancer; 1988; 75(3):271-80. PubMed ID: 3370323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of follow-up bone scans in the management of postoperative breast cancer--when should it be performed?].
    Suzuki T; Watarai J; Ohgushi M; Adachi M; Yamaguchi K
    Gan No Rinsho; 1987 Sep; 33(11):1314-7. PubMed ID: 3669318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photon-deficient finding in sternum on bone scintigraphy in patients with malignant disease.
    Otsuka N; Fukunaga M; Morita K; Ono S; Nagai K
    Radiat Med; 1990; 8(5):168-72. PubMed ID: 2075233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma.
    Stieber P; Nagel D; Ritzke C; Rössler N; Kirsch CM; Eiermann W; Fateh-Moghadam A
    Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):809-14. PubMed ID: 1489855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The value of routine bone scintigraphy in primary operable breast cancer].
    Thomsen HS; Munck O; Andersen KW
    Ugeskr Laeger; 1984 Jun; 146(26):1915-8. PubMed ID: 6506284
    [No Abstract]   [Full Text] [Related]  

  • 32. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 33. [Value of skeletal scintigraphy in the follow-up of breast cancer].
    Langhammer HR; Sondershaus S; Lauer O; Steuer G; Bauer R
    Fortschr Med; 1983 Mar; 101(10):429-34. PubMed ID: 6840646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What do breast cancer patients benefit from staging bone scintigraphy?
    Koizumi M; Yoshimoto M; Kasumi F; Ogata E
    Jpn J Clin Oncol; 2001 Jun; 31(6):263-9. PubMed ID: 11463804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is bone scintigraphy still required for screening metastatic bone disease?].
    Munz DL
    Nuklearmedizin; 1994 Aug; 33(4):5-6, 9-10. PubMed ID: 7971293
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma.
    Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Skopljak A
    Bosn J Basic Med Sci; 2006 Feb; 6(1):75-7. PubMed ID: 16533185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone scintigram of breast cancer patients and its indications].
    Shichijo Y; Inoue Y; Ibukuro K; Nishi T; Hirose T
    Rinsho Hoshasen; 1986 Mar; 31(3):359-62. PubMed ID: 3723827
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bone scintigraphy for the staging of lymphogranulomatosis?].
    Hundeshagen H; Diehl V; Creutzig H
    Strahlentherapie; 1985 Aug; 161(8):502-5. PubMed ID: 4024169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal scintigraphy in breast cancer management.
    Bares R
    Q J Nucl Med; 1998 Mar; 42(1):43-8. PubMed ID: 9646644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unifocal bone findings by scintigraphy. Clinical significance in patients with known primary cancer.
    Rappaport AH; Hoffer PB; Genant HK
    West J Med; 1978 Sep; 129(3):188-92. PubMed ID: 706356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.